biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by KayakerBCon Feb 10, 2016 5:55pm

83 Views

Post# 24545476

RE:RE:RE:RE:RE:RE:RE:Anybody know...?

everyone elses gold standard compound in other fields are getting paid huge sums of money, have way higher values and are in the crosshairs of the media in one form or another....

j.d...why do you think that our goldstandard technology has not been or isnt being valued as other gold standard products or technologies out there?

With no licensing deals and no clinical trials yet, why would you expect anything different?

No deals, no clinical trials = no stock price increase. I'm trying to remember..... Has that been explained 410 times or just 409 ??????? YOU used to post that the stock was going to go nowhere until clinical trials. HERE is one such post of yours.

Bullboard Posts

Barrick Gold employees detained in Mali amid ongoing dispute